Selenium compounds have emerged as promising chemotherapeutic agents with proposed epigenetic effects, however the mechanisms and downstream effects are yet to be studied. Here we assessed the effects of the inorganic selenium compound selenite and the organic form methylseleninic acid (MSA) in a leukemic cell line K562, on active (histone H3 lysine 9 acetylation, H3K9ac and histone H3 lysine 4 tri-methylation, H3K4me3) and repressive (histone H3 lysine 9 tri-methylation, H3K9me3) histone marks by Chromatin immunoprecipitation followed by DNA sequencing (ChIP-Seq). Both selenite and MSA had major effects on histone marks but the effects of MSA were more pronounced. Gene ontology analysis revealed that selenite affected genes involved in response to oxygen and hypoxia, whereas MSA affected distinct gene sets associated with cell adhesion and glucocorticoid receptors, also apparent by global gene expression analysis using RNA sequencing. The correlation to adhesion was functionally confirmed by a significantly weakened ability of MSA treated cells to attach to fibronectin and linked to decreased expression of integrin beta 1. A striking loss of cellular adhesion was also confirmed in primary patient AML cells. Recent strategies to enhance the cytotoxicity of chemotherapeutic drugs by disrupting the interaction between leukemic and stromal cells in the bone marrow are of increasing interest; and organic selenium compounds like MSA might be promising candidates. In conclusion, these results provide new insight on the mechanism of action of selenium compounds, and will be of value for the understanding, usage, and development of new selenium compounds as anticancer agents.
Introduction
Due to the generally highly proliferative state, tumor cells have an aberrant metabolism and generate more reactive oxygen species (ROS) than normal cells. In response to higher levels of ROS, cancer cells increases their antioxidant capacity, forcing them to maximize their antioxidant capacity and subsequently making them more vulnerable to additional ROS production [1, 2] . Thus, the generation of oxidative stress has lately been proven as a potential anticancer treatment. Selenium (Se) is an essential trace element crucial to mammalian cellular and biological functions, such as antioxidant and anti-inflammatory effects [3] . Per contra, in excessive amounts Se is toxic and turns into a pro-oxidant with growth inhibiting and cytotoxic properties [3] . In addition, there is a selective uptake of Se in tumors, the first evidence dating back to the 1960s when 75 Se-sodium selenite was assessed as a well as the experimental model used play crucial roles in the efficacy and toxicity of these compounds. Notably, the redox active and organic forms have shown to possess far more promising effects [2, 6] . Previous studies have shown specific selenite cytotoxicity in primary leukemic cells, where normal bone marrow or peripheral blood cells were unaffected [7] . In addition, in an ex vivo panel of primary AML cells, selenium, in its inorganic form Selenite (SeO 3 2-), was shown to be the most efficient drug when compared to conventional cytostatic agents [8] . Selenite has shown cytotoxic effects in several solid tumors as well as hematological malignancies [8, 9] , unfortunately its significant systemic and organospecific toxic effects has diminished its potential as a drug for clinical use [3] . An early case report, treating an AML patient with high doses of the organic Se form, selenocystine, showed promising results [10] . Another organic Se compound methylseleninic acid (MSA) has shown cytotoxicity in tumors at lower concentrations and with fewer side effects than selenite [3] . The molecular mechanisms underlying the favorable effects of selenium compound therapies are however yet insufficiently understood. One proposed mechanism, in addition to the pro-oxidative properties of Se compounds, is the induction of epigenetic alterations, by inhibiting HDAC activity and modulating histone marks [11, 12] . Selenite and MSA both increase the total protein level of active chromatin mark H3K9ac with a corresponding decrease in the repressive chromatin mark H3K9me3 protein levels in prostate cancer cells [13] . MSA has also been shown to inhibit HDAC activity in diffuse large B-cell lymphoma lines [11] and esophageal squamous cell carcinoma [14] . A recent study reported a decrease of H3K9me3 and increased H4K16ac after MSA treatment in the breast cancer cell line MCF-7, while selenite decreased the latter histone mark [15] . However, these studies did not assess the distribution of active and repressive chromatin marks across the genome or the downstream effects of the compound and resulting effects on target genes and epigenetic factors, and has not been conducted in a leukemic background. There is however, growing evidence of epigenetic aberrations in AML [16, 17] .
This study was undertaken to explore the genome wide epigenetic alterations caused by the inorganic selenium compound selenite and the organic form MSA, with the aim to increase the knowledge of the specific cytotoxic effects exerted by respective compounds. Here we show for the first time not only how these compounds affect key histone modifications in leukemia cells, but also how selenite and MSA epigenetically provoke different gene sets that are linked to their cytotoxic profile. In addition, new insight on the cytotoxic mechanism of MSA is uncovered, connected to loss of adhesion and epigenetic effects on glucocorticoid receptors.
Materials and methods

Cell culture
Human chronic myeloid leukemia cells -K562, were cultivated in RPMI 1640 medium (Lonza) supplemented with 10% fetal bovine serum (Lonza) and 1% glutamine (Lonza). On the day of the treatment the culture medium was changed to fresh medium to obtain a 0.7 × 10 6 cells/ml suspension. Primary AML cells from bone marrow of four patients (one male and three females) were sampled at the time of diagnosis. The average age of patients was 62 years and their mean age ranged from 38 to 84 years. Three patients have had the de novo AML subtype and the fourth patient had secondary AML. The average number of blasts in the patients was 65.5%. Mononuclear cells were separated using density gradient by Ficoll separation (Lonza) and then vitally frozen. At the time of the experiment cells were thawed, cultured and seeded at a density of 2.2 × 10 5 cells/ml in RPMI 1640 medium (Lonza) supplemented with 10% fetal bovine serum (Lonza). The cells were treated with 6 µM selenite (Sigma) or 5 µM MSA (Sigma) for 24 h and incubated in a humidified incubator at 37°C and 5% CO 2 . Cell viability was measured using the neutral red assay as well as the MTT assay. Experiments involving human material were approved by the Regional Ethical Committee in Stockholm.
Nuclear protein extraction and HDAC activity assay
Post treatment, cell pellets were washed with PBS followed by centrifugation for 10 m at 1800×g in 4°C. A second wash was done using a hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2, 10 mM KCl, 0.5 mM DTT) supplemented with cOmplete™ Protease Inhibitor Cocktail (Roche) and the suspension was centrifuged again for 5 m at 4°C (1800×g). The cells were then suspended in the hypotonic buffer and incubated on ice for 10 m. The samples were homogenized by passing the cell suspension 5 times through a 23G syringe and 27G syringe each, before centrifugation for 15 m at 4°C (3300×g). The nuclear pellets were suspended in a TNM buffer (0.1 M NaCl, 0.3 M sucrose, 10 mM Tris-HCl (pH 7.4), 2 mM MgCl 2 , 0.5% NonidetP-40, 1% glycerol, 0.5 mM DTT (all from Sigma-Aldrich), cOmplete™ Protease Inhibitor Cocktail (Roche) and incubated on ice for 10 m before sonication for 15 s with an output of 70% with a Microson™ Ultrasonic cell disruptor XL (Misonix). The samples were centrifuged for 10 m at 4°C (10,000×g) and the supernatants were collected and frozen at −80°C. The protein concentration was determined using the Bio-Rad protein assay (Bio-Rad) according to the manufacturer's instructions. The nuclear HDAC activity was determined using the HDAC Activity Fluorometric Assay Kit (BioVision) following instructions from the manufacturer. Trichostatin A and HeLa cell extracts, provided in this kit were used as negative and positive controls respectively according to manufacturer's instructions.
Luminometric methylation assay (LUMA)
DNA was extracted and purified using the Isolate II Genomic DNA Kit (Bioline) following instructions from the manufacturer. DNA concentration was determined using the Nanodrop 2000 Spectrophotometer (Thermo Fischer Scientific). Genome-wide DNA methylation was assessed using the Luminometric Methylation Assay as described in detail by Karimi et al. [18] .
Western blot
Nuclear extracts containing 20 µg of proteins were separated on a Bolt TM 4-12% Bis-Tris Gel (Novex) and transferred to a nitrocellulose membrane using the iBlot Gel Transfer Device (Invitrogen). Five different primary antibodies were used in separate membrane strips, all of rabbit polyclonal origin and with anti-human histone specificity for: H3 (tri-methyl K9) (ab8988, Abcam), H3 (tri-methyl K4) (AB-001-0024, Diagenode), H3 (acetyl K9) (ab4441, Abcam); total H3 (06-755, Millipore), β-actin (A5441, Sigma-Aldrich). Incubation with primary antibody diluted in TBST containing 3.5% bovine serum albumin (BSA) was done overnight at 4°C. Secondary antibodies (1:5000 in TBST with 5% dry milk) were incubated for 1 h. Membranes were developed using the Amersham™ ECL™ Start Western Blotting Detection Reagent (GE Healthcare) and bands were visualized using the Bio-Rad Quantity One imaging system (Bio-Rad).
2.5. Chromatin immunoprecipitation (ChIP), sequencing and ChIP-qPCR K562 cells were collected by centrifugation post treatment, resuspended in PBS and fixed in Formaldehyde (Sigma Aldrich) with 8 m incubation at room temperature. ChIP was performed using the iDeal ChIP-Seq kit set for Histones (AB-001-0024, Diagenode) following manufacturer's instructions. For chromatin shearing, sonication was performed in shearing buffer in 1.5 ml TPX microtubes (C30010010-300, Diagenode) sonicated using the Bioruptor sonicator (B01020001, Diagenode) with 25 sonication cycles. For the magnetic immunoprecipitation 1 µl of ChIP-seq grade control antibody was added per tube with 100 µl of sheared chromatin corresponding to 1 × 10 6 cells (same ChIP grade antibodies as for western blot were used). After chromatin decrosslinking the fragmented DNA was purified with the MiniElute PCR Purification Kit (28004, Qiagen) and the DNA concentration was measured using Qubit Fluorometric Quantitation with High Sensitivity (Q32851, Thermo Fischer Scientific). The samples were further used for sequencing and ChIP-qPCR as mentioned below.
The library was prepared using the ThruPLEX DNA-seq Kit (R400428, Rubicon Genomics) following instructions of manufacturer. Once finished, the quality of samples was evaluated with the 2100 Bioanalyzer system (Agilent Technologies) and the library clean up and size selection was done using the Agencourt® AMPure® XP magnetic beads (Qiagen). DNA concentration was measured using Qubit and up to 6 samples with different barcodes per lane were pooled to a maximum concentration of 1 ng/µl. 7 pmol of each library with 1% PhiX, was hybridized to the flow cell. Clusters were generated with the cBot, and the flow cell was sequenced on the Illumina HiSeq. 2000 with single end sequencing. As a primary quality control of the sequencing the intensities and base calling parameters were checked (using default parameter settings) with the HiSeq Control software, followed by demultiplexing of the libraries.
Bioinformatic analysis
The raw sequencing reads in FASTQ format were quality control checked with the FASTQC tool (version 0.11.4) (Babraham Bioinformatics), and eventual adapter sequences and duplicates were removed in order to get at least 10 × 10 6 filtered reads. The filtered data was then mapped using Bowtie (version 2.2.6) to the human reference genome issue HG-19 (https://www.ncbi.nlm.nih.gov/grc/ human/issues/HG-19), with the requirement of unique alignment. Bedgraphs were generated using BED tools (version 2.16.2) and the data was visualized as custom tracks with the UCSC genome browser (https://genome.ucsc.edu). Peakcalling was performed with HOMER (version 4.8) (http://homer.salk.edu.homer/) to determine enrichment over the input samples across the whole genome. Peak size for narrow peaks was set to 150 bp, and 500 bp for broad peaks. The enriched regions were then annotated to the closest transcription start site using HOMER, and differential analysis between treated and control samples was performed with edgeR (version 3.14.0) (Bioconductor). As a cut off for further downstream analysis a logarithm of fold change (log FC) greater than or equal to 2, and log FC less than or equal to −2 was used.
RNA sequencing
Post treatment, RNA was extracted and purified from K562 cells using the RNeasy Plus Mini Kit (Qiagen) with on column DNase digestion according to manufacturer's instructions. RNA concentration was determined using the Nanodrop 2000 Spectrophotometer (Thermo Fischer Scientific). The experiment was performed in three biological replicates. RNA-Sequencing, to reveal the presence and quantity of the entire transcriptome, after MSA treatment, was performed at the Beijing Genomics Institute (BGI), China, and surveyed in a very highthroughput and quantitative manner at single-base resolution. The RNA-Sequencing was executed with the BGISEQ-500 sequencing system.
Quantitative polymerase chain reaction (qPCR)
Following RNA extraction, first strand cDNA was generated by reverse transcription using the Thermo Scientific Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Fischer Scientific), using 1 µg template RNA according to the protocol provided by the manufacturer. All the qPCRs were performed in duplicates on 96-well plates using a PikoReal Real-Time PCR System (Thermo Fischer Scientific) and Luminaris Color HiGreen Master Mix (Thermo Fischer Scientific). The final reaction volume was 10 µl and contained 0.1 µl of cDNA per reaction. Refer Supplementary information for primer sequences. All primer pairs had an efficiency of 100% +/−5%. The PCR program used was 50°C 2 min, 95°C 2 min, 95°C 15 s and 60°C 30 s (40 cycles). Results were analysed using the 2 -ΔΔC T method, and β-actin was used as endogenous control.
For ChIP-qPCR, purified DNA obtained after the ChIP was used as template (150 ng DNA per reaction) and amplified for target genes as mentioned above. Enrichment for H3K9Ac was validated by qPCR with primers specific for the target genes in their promoter regions and the expression was normalized to percentage of input sample, that is a part of the sample not subjected to ChIP.
Flow cytometry
Post treatment, 5 × 10 5 cells were incubated with CD29 (integrin β1, ITGB1) (FITC conjugate, clone MEM-101A, Thermo Fischer Scientific), for 30 m at 4°C in the dark. Cells were fixed in 1% paraformaldehyde at 4°C and analysed on a FACSCanto II (BD Biosciences) flow cytometer. The data were analysed using FlowJo software (Treestar).
Adhesion assay
K562 and AML cells at a density of 7 × 10 5 cells/ml were treated with MSA 5 µM or vehicle for 24 h and 20 h respectively. The adhesion assay was performed with a modified procedure described by Damiano et al. [19] . Briefly, a human fibronectin coated 96 well plate (Corning) was blocked for one hour at room temperature with 1% BSA. Wells were washed once with serum-free RPMI 1% glutamine and 50,000 cells were added per well and allowed to attach for 3 h at 37°C. After the incubation, wells were washed three times with medium to remove unattached cells. Adherent cells were then fixed with 70% methanol for 10 m and incubated with a 0.5% crystal violet 20% methanol solution for additional 10 m and washed with water. Absorbance was read at 590 nm.
Statistics analysis
All numerical data are presented as a mean of three independent experiments unless otherwise stated. Statistical analyses were performed using GraphPad PRISM software. Students's 't-test' was applied to the data obtained and P values less than 0.05 were considered statistically significant. The statistical methods used, for the bioinformatics, in the differential analysis are multi-group statistical testing developed by Robinson and Smyth [20, 21] .
Results
Global effects of selenite and MSA on epigenetic marks
Based on viability titration experiments, 6 µM of selenite and 5 µM of MSA were chosen to achieve moderate toxicity in all experiments (approximately 20% cell death after 24 h treatment) (Fig. 1A) . As a control to check the specificity of these compounds towards the tumor cells, human buffy coat from five healthy donors were treated with 10 µM of selenite or MSA for 24 h, and no significant cell death was observed after treatment with neither of the two compounds (Control: 100% viability ± 9 std.dev, Selenite: 89% viability ± 17 std.dev, MSA: 97% viability ± 16 std.dev). The epigenetic alterations in K562 cells were examined on a global level in terms of alterations of total nuclear HDAC activity, which upon 24 h treatment showed a tendency to decreased approximately 10% with selenite and MSA respectively (Fig. 1B) . However, these results were not statistically significant. In order to determine the potential impact of the two selenium compounds on total genomic DNA methylation, the LUMA technique was used, but again no significant changes were observed (Fig. 1C) . Previous studies have shown that Se compounds modify histones via post-translational modifications (PTMs) on a global level, detecting acetylated and methylated histone proteins by western blot in different cell lines [13, 22] . Therefore, the effects of selenite and MSA on the occurrence of specific acetylation and methylation sites on H3K4me3, H3K9me3 and H3K9ac were studied using Western Blot. The results displayed that after 24 h the active histone mark, H3K4me3 was strongly upregulated upon MSA treatment and H3K9ac as well as H3K9me3 showed a clear tendency of enrichment. However, selenite treatment did not significantly alter these histone marks (Fig. 1D ).
Genome wide changes in active and repressive histone marks upon MSA and selenite treatment
ChIP followed by whole genome sequencing was performed using antibodies against active (H3K9ac, H3K4me3) and repressive (H3K9me3) histone marks, after 24 h treatment of cells with selenite or MSA. ChIP sequencing data was assessed after defining peak size as 150 bp for H3K9ac and H3K4me3, and 500 bp for H3K9me3. Peaks annotated were 5386 of 65242 for H3K9ac, 5382 of 60685 peaks for H3K4me3 and 683 of 82781 peaks for H3K9me3. In a first evaluation of the results, the data were selected based on a two log fold change (log2FC) between the control and treated samples, after subtraction of the input of each sample.
The global effects on number and partial overlap of protein coding genes affected by selenite and MSA are illustrated with Venn-diagrams ( Fig. 2A) . Overall, MSA induced changes in histone modifications in a larger number of genes compared to selenite however, for both active and repressive histone marks, there are sites of increased as well as decreased enrichments of the respective histone mark. While roughly half of the genes affected by selenite overlap with MSA (H3K9ac), the majority of the genes affected by MSA display no overlap with selenite.
The difference in overall changes of histone modifications between the two compounds is visualized in heat maps (Fig. 2B-C) , were the genes with the highest or lowest log FC after MSA treatment are illustrated for H3K9ac. The genes that show the highest change in enrichment for MSA were barely affected by selenite, and selenite instead showed histone modification patterns similar to the control sample. Similar patterns are seen for H3K9me3 and H3K4me3 ( Supplementary  Fig. 1 ).
ChIP sequencing data analysis
The log2FC compared to control was used as criteria for the gene ontology (GO) analysis, including both up-and downregulated genes and ranked according to fold change. Listed in Table 1 are the GO pathways of molecular functions and cellular components that have been significantly affected by MSA for H3K9ac. In Fig. 3 , a graphical overview of significantly enriched GO pathways (from Table 1 ) after MSA treatment are illustrated, and display a clear effect on cell adhesion, as well as glucocorticoid receptor binding and Inositol-3-phosphate synthase activity. The GO terms of biological processes significantly affected by MSA for H3K4me3 are listed in Supplementary  Table 1 , wherein the most pronouncedly affected categories were connected to cell adhesion. These adhesion categories remained unaffected by selenite after 24 h of treatment and therefore seem to be very specific MSA effects.
As selenite is known to trigger oxidative stress by generation of ROS, with the consequence of upregulating the expression of genes that can counteract the effect [8, 23] , logFC > 2 was selected for GO analysis to explore if an increase in enrichment was evident epigenetically as well. Only H3K9ac had significantly altered peaks to display significant changes in GO, but it is clear that the biological processes affected by 
by neutral red assay, after treatment for 24 h with 5 µM selenite or 6 µM MSA. B) Nuclear HDAC activity after incubation with selenite or MSA for 2 or 24 h. Trichostatin A and HeLa cell extracts were used as negative and positive controls respectively. C) Global DNA methylation determined by LUMA, after incubation with selenite or MSA for 24 h. D) Western blot analysis of H3K9ac, H3K9me3 and H3K4me3 after treatment with selenite (S) or MSA (M) for 24 h (representative figure out of three independent experiments). Graphs show quantification of H3K9ac, H3K9me3 and H3K4me3 proteins normalized by beta-actin. Selenite and MSA treated samples were compared to the control and the levels of significance were calculated using t-test for independent samples (ns: non-significant, **p ≤ 0.01, ***p ≤ 0.001). Data presented represents the mean out of at least three independent experiments. selenite for H3K9ac to a high degree represent responses to oxygen and hypoxia (Table 2) .
Analysis of RNA sequencing after MSA treatment
In order to explore the downstream effects of the chromatin modifications caused by MSA, the RNA transcriptome of the same samples were sequenced and quantified. Differentially expressed genes (DEGs) were screened using Possion Distribution method in order to perform further functional analysis. As a cut off for downstream analysis a log FC ≥ 2 and log FC ≤−2 was set. Also, correction of p-value corresponding to DEGs was performed using Bonferroni method and corrections for false positives and false negatives errors were performed using the FDR method. FDR value ≤ 0.001 and absolute value of log2Ratio ≥ 1 was set as threshold to judge the significance of DEGs. Fig. 4 illustrates the total number of genes that have been significantly up or downregulated by MSA (Fig. 4A) and Selenite (Fig. 4B) . Amongst the two, MSA displays more pronounced DEGs (979 up and 470 downregulated) as compared to Selenite (27 up and 18 downregulated). Further GO analysis was performed on the DEGs, both up and downregulated, after MSA treatment and a graphical overview of significantly enriched GO terms with molecular functions is shown in Fig. 4C . In concordance to the ChIP sequencing results (Fig. 3) , the GOs significantly altered by MSA observed after RNA sequencing are the categories related to cellular binding and adhesion (Fig. 4C) . A comparative study of significantly enriched GOs after MSA treatment obtained by both RNA-and ChIP-sequencing (H3K9Ac) analysis was performed and illustrated in Fig. 4D .
Genes such as CD29, disabled homolog 2 (DAB2), huntingtin interacting protein 1 (HIP1), syndecan 1 (SDC1), leukocyte differentiation antigen (CD84) and tetraspanin 29 (TSPAN29, CD9), linked to cellular adhesion, were found to be differentially regulated after MSA treatment as observed in both RNA-and ChIP-sequencing (H3K9Ac) analysis ( Fig. 4C and D) . Further, in order to validate our findings and study the early cytotoxic effects, a ChIP-qPCR with active chromatin mark H3K9Ac was performed after 3, 6 and 24 h of MSA treatment. The genes DAB2 and HIP1 are significantly downregulated (H3K9Ac decreased) after 3 h of treatment and the CD29 is significantly downregulated after 6 h of treatment (Fig. 5A) . Also, mRNA expression of these genes was examined by qPCR after 6 h and 24 h of MSA treatment. The levels of CD29, DAB2, HIP1 and CD9 mRNA after 6 h of MSA treatment were significantly decreased whereas the CD84 and SDC1 showed significant increase their mRNA expression (Fig. 5B) . Apart from DAB2, selenite did not show any significant changes in mRNA expression of these genes (Fig. 5B) . The transient effect observed at 6 h reflects that it is an early event, preceded by histone alterations, and might be involved in the cytotoxic effects caused by MSA, and reinforce the findings that selenite and MSA have different mechanism of action. Other DEGs connected to cell adhesion that were significantly affected in the ChIP sequencing analysis but not in the RNA sequence analysis, were also investigated by qPCR after 6 and 24 h of treatment. As seen in Fig. 5C all three genes examined (MET, RICTOR and ZEB1) show clear increase in mRNA level after a 6 h of treatment with MSA but not after selenite treatment thus confirming the ChIP sequencing results.
Adhesion analysis based on ChIP sequencing data
To explore if the enrichment found from the ChIP sequencing by MSA is translated into functional changes, adhesion properties of K562 cells were investigated after treatment with MSA. One gene that is of great importance in the adhesion of hematopoietic cells to the extracellular matrix (ECM), and that was found to have an altered enrichment for H3K9ac after MSA treatment, was CD29. The peaks from the promoter region for CD29 for active chromatin marks H3K9ac and H3K4me3 in the ChIP sequencing data (Fig. 6A ) displayed a clear decrease upon MSA treatment. CD29 was confirmed to be significantly decreased after 24 h treatment with MSA by flow cytometry (Fig. 6B) . Furthermore, to establish whether this decrease in CD29 truly had an effect on the cell's ability to attach to a surface, adhesion analysis was performed, and revealed that cells treated with MSA had a significant impaired ability to adhere onto the fibronectin coated plate (Fig. 6C) . The loss of adhesion after MSA treatment was also confirmed using primary AML cells derived from the bone marrow of 4 different patients. In the primary cells a 45% loss in adhesion was observed following MSA treatment without significantly affecting the cell viability (Control: 100% viability ± 13.0 std. dev, Selenite: 85.04% viability ± 9.8 std. dev, MSA: 97.95% viability ± 5.1 std. dev) (Fig. 6D) .
Discussion
The purpose of this study was to examine the role of genome wide epigenetic changes in the cytotoxic mechanism of action of the inorganic selenite and organic MSA. The initial findings from the ChIP sequencing showed not only that the compounds had caused profound histone modifications, but also that there seemed to be large differences between selenite and MSA. The Venn-diagrams show that MSA affects a larger number of genes and that many are specific for this compound. The distinct effects of the two compounds are also evident in the heat maps and in the GO analyses. Selenite, which is well known to mediate its cytotoxic effect through generation of ROS [24] , mainly superoxide, had a significant enrichment of H3K9ac of genes within the GO terms for biological processes for oxygen response and hypoxia, as expected. Despite K562 cells being p53 negative, which has been shown to inhibit the cytotoxic effect of selenite in AML cells [25] , ROS dependent cytotoxic effects in K562 by selenite has been previously reported. In the aforementioned study, a correlation between toxicity caused by ROS generation after selenite treatment and induction of topo II-DNA complexes was observed. These effects were shown to occur in a time-dependent manner and correlated with the induction of apoptosis [26] .
The cytotoxic effects exerted by MSA are in contrarily not solely mediated by superoxide or hydrogen peroxide but suggested to be via a different mechanism [27] . Our results, showing that the GO enrichment sites obtained for MSA are almost completely different from the ones obtained for selenite, strengthen these results. The GO analysis of our ChIP sequencing data revealed very relevant and specific effects of MSA on genes sets connected to cell adhesion and glucocorticoid receptor binding. The latter being very interesting as Prasad et al. recently reported a homozygote mutation of the selenoprotein thioredoxin reductase 2 in humans giving rise to glucocorticoid deficiency [9] .
The effect of MSA on adhesion might have a clinical relevance as the interaction between leukemic cells and bone marrow stroma plays a vital role in both the prognosis of leukemia and of the development of drug-resistance of leukemic cells [28] . A plausible explanation is that leukemia stem cells (LSC) can be dormant in the bone marrow niche [29] taking advantage of this rich and protective environment to escape from chemotherapeutic treatments [30, 31] . This is also an important cause of the poor efficacy of some targeted leukemia stem cell therapies [32] [33] [34] . Therefore, understanding and finding new ways to disrupt the interaction of leukemic cells and stromal cells, as an approach to enhance the cytotoxicity of chemotherapeutic drugs is of utmost interest. In a study by Garrido et al., direct contact with human bone marrow stromal cells reduced drug-induced apoptosis of AML cells [35] . Causing these LSCs to detach from the bone marrow could therefore make them more vulnerable to chemotherapy.
The most relevant adhesion molecules as of now include CD44, integrins and selectins. In our data set CD29, one of the protein coding genes with altered enrichment caught our attention. The altered enrichments of CD29 also translated down to protein level, and had a significant effect on the adhesion of cells to fibronectin. Maybe even more importantly, the same finding, with loss of adhesion, was also observed in human primary AML cells from the bone marrow, strongly indicating that MSA might contribute to the detachment of cells from the ECM in the bone marrow. Recently, the critical role of integrins in minimal residual disease (MRD) persistence and LSC homing has been further strengthened by observations where overexpression of α6 and β4 integrins enhanced drug resistance by increasing laminin adhesion of EVI1 positive AML cells [36] . Due to the role of integrins in homing of lymphoid tumor cells to their metastatic sites, integrin targeting in LSCs might theoretically also be an approach to prevent colonization of organs by leukemic cells [37] . The effect on adhesion and integrins by MSA is also well connected to previous reports showing the significant effect of MSA on calcium ion signaling and calcium channel activity, as increase of intracellular Ca 2+ levels stimulated by integrin-mediated adhesion have been demonstrated [38, 39] . The connection between Ca 2+ and adhesion caused by MSA requires further studies to understand the exact mechanism of action, especially considering that the calcium dependent cadherins were also found to be epigenetically affected. It is well documented that MSA has suppressive effects on phospho-Akt (Ser473) expression, and that in the presence of a calcium chelator or a specific inhibitor of calcineurin (a calcium-dependent phosphatase), this effect is greatly reduced [40] . CD9, a tetraspanin protein, has been implicated in various physiological processes like motility, adhesion and fertilization [41] and plays a critical role in tumor progression and metastasis [42] [43] [44] . Several lymphoblastic leukemia's can be distinguished on the basis of their CD9 expression [45, 46] . Also it has been shown that CD9 upregulates the adhesion of B leukemic cells to fibronectin and the migration of these cells in response to CXCL12, through a RAC1 dependent pathway, further suggesting a possible key role in late relapse of B acute lymphoblastic leukemia through its effects on migration and homing. [47] . These findings are in concordance with our study wherein we find that both the CD9 and CD29 are downregulated upon MSA treatment and further affects the adhesion of human chronic myeloid leukemia cells as well as primary AML cells.
Additional genes related to cell-cell and/or cell-matrix adhesion and regulation of CD29 such as DAB2 [48, 49] , HIP1 [50, 51] , SDC1 [52] were significantly regulated by MSA treatment via PTMs and/or mRNA expression, but their protein levels and activity needs to be further examined. DAB2 has for example been suggested as a putative tumor suppressor, and its expression is downregulated in various tumor cells and it inhibits cell proliferation by inhibiting growth factor signaling [53] However, DAB2 has been shown to affect migration, by promoting TGF beta induced gene expression of VEGF and FGF2 in cancer cells [54, 55] , suggesting that DAB2 can also promote cancer progression. DAB2 has also shown to regulate cell-cell and cell-fibrinogen adhesion, integrin αIIbβ3 activation and positive regulation of fibrinogen uptake [56, 57] . Our results show that MSA treatment significantly decreased the DAB2 expression and therefore might have further lead to loss of cell-cell and/or cell-matrix adhesion.
HIP1, first implicated in cancer biology as a part of chromosomal translocation in leukemia, is a cofactor in clathrin-mediated vesicle trafficking and a key player in cell migration [58] . Clathrin light chain (CLC)-HIP1 interactions are needed for recycling of active CD29 and necessary for cell migration [50] . In addition, HIP1 has been shown to mediate CD29 turnover following c-met activation [51] . In this study, Fig. 3 . Graphical overview of significantly enriched GO categories after MSA treatment (log2FC) in K562 cells. A) Molecular functions and B) Cellular components. A child node represents a more specific instance of a parent node, to which it is connected with. Red boxes represent significantly enriched GO categories and black boxes represent non-enriched GO categories that are included in the graph to allow tracing of the interrelationships between the GO categories. we found that MSA downregulates the expression of HIP1 which partly might explain the decrease in CD29 expression. SDC1, significantly affected by MSA, has been found to be dysregulated in several cancer forms where altered expression is connected to cancer progression (37) . RICTOR-mTOR, herein also significantly affected by MSA via both PTMs and mRNA expression, was previously shown to be required for AKT Ser473 phosphorylation. AKT Ser473 phosphorylation in turn, significantly contributes to CD29 mediated anchoring dependent survival of cells [59, 60] . The suppressive effect of MSA on Ser473 phosphorylation might therefore possibly be via the epigenetic alterations of and 24 h, as observed in ChIP-qPCR. B) Relative mRNA expression of the DEGs. C) Genes that were significantly changed as observed in ChIP sequencing analysis but not in RNA sequencing analysis. MSA and/or selenite treated samples were compared to the control and the levels of significance were calculated using t-test for independent samples (ns: nonsignificant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001). B-E represents the mean out of at least three independent experiments.
RICTOR. Overall, the findings from the ChIP sequencing translated well to the genes examined on both protein and mRNA levels, and the effect observed at the mRNA level occurred at a relative early time point, prior to any signs of cell death. This indicates that the effects observed on gene expression after MSA treatment at least partially could be explained via histone PTMs.
Conclusions
Our study shows that selenium compounds -MSA and selenite affect histone modifications on a global level in a distinct way. Selenite mainly affected pathways involving oxygen and hypoxia responses, while MSA affected adhesion and migration pathways. Further studies are needed to elucidate whether these are direct or indirect epigenetic effects. Nevertheless, it is the first study undertaken to explore the genome wide epigenetic effects of these selenium compounds, and will hopefully lay ground for exploring the anti-carcinogenic effects of these compounds further. Targeting adhesion proteins with MSA might help in detaching the leukemia stem cells from the bone marrow and subsequently overcoming the resistance phenotype in combination therapy with other conventional cytostatic agents.
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